<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01947517</url>
  </required_header>
  <id_info>
    <org_study_id>Punctal plugs</org_study_id>
    <nct_id>NCT01947517</nct_id>
  </id_info>
  <brief_title>The Retention Rate Between Brand A and Brand B Punctal Plugs</brief_title>
  <official_title>The Retention Rate Between Superflex Punctal Plugs, and Parasol Punctal Occluders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Queen's University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Queen's University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if Parasol punctal occluders (Brand A) have a
      higher rate of retention than Superflex punctal plugs (Brand B).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Eyes will be randomized to either Brand A or Brand B punctal plug. The primary outcome
      measure is length of time punctual plugs are retained, measured in months. This will be
      measured at monthly assessments for 6 months. Secondary outcome measures include patient
      satisfaction, and improvement in subjective and objective dry eye scores, as well as
      complications related to punctual plugs including spontaneous plug loss, and intolerance. We
      will evaluate these measures by repeating the Canadian Dry Eye Assessment, Schirmer 1, tear
      meniscus height, fluorescein corneal staining (NEI scale), and lissamine green conjunctival
      staining (NEI scale) at month 1, month 3, and month 6 visits.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Actual">August 2014</completion_date>
  <primary_completion_date type="Actual">May 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Length of Retention</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Canadian Dry Eye Assessment Score</measure>
    <time_frame>6 months</time_frame>
    <description>Describes the scores on a scale and range from 0-3. Higher score represents more severe dry eye. Score 0 = no dry eye symptoms, score 1 = mild dry eye symptoms, score 2 = moderate dry eye symptoms, score 3 = severe dry eye symptoms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>National Eye Institute Corneal Fluorescein Staining Pattern</measure>
    <time_frame>6 months</time_frame>
    <description>The cornea is divided into 5 zones, and the inferior zone 5 was assessed for staining pattern. Grade 0= no staining, grade 1= trace staining, grade 2= mild staining, grade 3= moderate staining, and grade 4= severe staining.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>National Eye Institute Grading for Conjunctival Staining</measure>
    <time_frame>6 months</time_frame>
    <description>The conjunctival staining is divided into 6 zones. Each zone received a score for staining with lissamine green. Grade 0= no staining, grade 1= trace staining, grade 2= mild staining, grade 3= moderate staining, grade 4= severe staining. Data from different zones was combined and the total value was averaged.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tear Meniscus Height</measure>
    <time_frame>6 months</time_frame>
    <description>Meniscus height measured in mm</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">52</enrollment>
  <condition>Dry Eye</condition>
  <arm_group>
    <arm_group_label>Parasol Punctal Occluder Group</arm_group_label>
    <description>Randomized to receive Brand A punctal plugs</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Superflex Punctal Occluder Group</arm_group_label>
    <description>Randomized to receive Group B punctal plugs</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Parasol Punctal Occluder</intervention_name>
    <description>Patients will be randomized to receive one of these 2 punctal occluders in the management of dry eyes.</description>
    <arm_group_label>Parasol Punctal Occluder Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Superflex Punctal Occluder</intervention_name>
    <description>Patients will be randomized to receive one of these 2 punctal occluders in the management of dry eyes.</description>
    <arm_group_label>Superflex Punctal Occluder Group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients will be recruited from cornea and general ophthalmology specialist practices at
        Hotel Dieu Hospital, Queens University
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  moderate dry eye, severe dry eye

        Exclusion Criteria:

          -  silicone allergy, punctal stenosis, punctal occlusion, punctal cautery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ashley R Brissette, BSc, MD</last_name>
    <role>Study Director</role>
    <affiliation>Queens University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stephanie Baxter, MD, FRCSC</last_name>
    <role>Principal Investigator</role>
    <affiliation>Queens University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Ophthalmology, Hotel Dieu Hospital</name>
      <address>
        <city>Kingston</city>
        <state>Ontario</state>
        <zip>K7L 5G2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 17, 2013</study_first_submitted>
  <study_first_submitted_qc>September 17, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2013</study_first_posted>
  <results_first_submitted>October 1, 2015</results_first_submitted>
  <results_first_submitted_qc>March 30, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">June 16, 2017</results_first_posted>
  <last_update_submitted>March 30, 2017</last_update_submitted>
  <last_update_submitted_qc>March 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 16, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Queen's University</investigator_affiliation>
    <investigator_full_name>Dr. Stephanie Baxter</investigator_full_name>
    <investigator_title>Program Director Department of Ophthalmology</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Parasol Group</title>
          <description>Randomized to receive Brand A punctal plugs
Parasol Punctal Occluder</description>
        </group>
        <group group_id="P2">
          <title>Superflex Group</title>
          <description>Randomized to receive Group B punctal plugs
Superflex Punctal Occluder</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="26"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Parasol Group</title>
          <description>Randomized to receive Brand A punctal plugs
Parasol Punctal Occluder</description>
        </group>
        <group group_id="B2">
          <title>Superflex Group</title>
          <description>Randomized to receive Group B punctal plugs
Superflex Punctal Occluder</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="25"/>
            <count group_id="B2" value="25"/>
            <count group_id="B3" value="50"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="39"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="61.7" spread="17.67"/>
                    <measurement group_id="B2" value="58.4" spread="16.18"/>
                    <measurement group_id="B3" value="60.1" spread="15.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="45"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Canada</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Length of Retention</title>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Parasol Group</title>
            <description>Randomized to receive Brand A punctal plugs
Parasol Punctal Occluder</description>
          </group>
          <group group_id="O2">
            <title>Superflex Group</title>
            <description>Randomized to receive Group B punctal plugs
Superflex Punctal Occluder</description>
          </group>
        </group_list>
        <measure>
          <title>Length of Retention</title>
          <units>months</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6" spread="0"/>
                    <measurement group_id="O2" value="6" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Canadian Dry Eye Assessment Score</title>
        <description>Describes the scores on a scale and range from 0-3. Higher score represents more severe dry eye. Score 0 = no dry eye symptoms, score 1 = mild dry eye symptoms, score 2 = moderate dry eye symptoms, score 3 = severe dry eye symptoms.</description>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Parasol Group</title>
            <description>Randomized to receive Brand A punctal plugs
Parasol Punctal Occluder</description>
          </group>
          <group group_id="O2">
            <title>Superflex Group</title>
            <description>Randomized to receive Group B punctal plugs
Superflex Punctal Occluder</description>
          </group>
        </group_list>
        <measure>
          <title>Canadian Dry Eye Assessment Score</title>
          <description>Describes the scores on a scale and range from 0-3. Higher score represents more severe dry eye. Score 0 = no dry eye symptoms, score 1 = mild dry eye symptoms, score 2 = moderate dry eye symptoms, score 3 = severe dry eye symptoms.</description>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.06" spread="1.081"/>
                    <measurement group_id="O2" value="0.25" spread="1.018"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>National Eye Institute Corneal Fluorescein Staining Pattern</title>
        <description>The cornea is divided into 5 zones, and the inferior zone 5 was assessed for staining pattern. Grade 0= no staining, grade 1= trace staining, grade 2= mild staining, grade 3= moderate staining, and grade 4= severe staining.</description>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Parasol Group</title>
            <description>Randomized to receive Brand A punctal plugs
Parasol Punctal Occluder</description>
          </group>
          <group group_id="O2">
            <title>Superflex Group</title>
            <description>Randomized to receive Group B punctal plugs
Superflex Punctal Occluder</description>
          </group>
        </group_list>
        <measure>
          <title>National Eye Institute Corneal Fluorescein Staining Pattern</title>
          <description>The cornea is divided into 5 zones, and the inferior zone 5 was assessed for staining pattern. Grade 0= no staining, grade 1= trace staining, grade 2= mild staining, grade 3= moderate staining, and grade 4= severe staining.</description>
          <units>Scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.28" spread="1.091"/>
                    <measurement group_id="O2" value="3.60" spread="0.756"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>National Eye Institute Grading for Conjunctival Staining</title>
        <description>The conjunctival staining is divided into 6 zones. Each zone received a score for staining with lissamine green. Grade 0= no staining, grade 1= trace staining, grade 2= mild staining, grade 3= moderate staining, grade 4= severe staining. Data from different zones was combined and the total value was averaged.</description>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Parasol Group</title>
            <description>Randomized to receive Brand A punctal plugs
Parasol Punctal Occluder</description>
          </group>
          <group group_id="O2">
            <title>Superflex Group</title>
            <description>Randomized to receive Group B punctal plugs
Superflex Punctal Occluder</description>
          </group>
        </group_list>
        <measure>
          <title>National Eye Institute Grading for Conjunctival Staining</title>
          <description>The conjunctival staining is divided into 6 zones. Each zone received a score for staining with lissamine green. Grade 0= no staining, grade 1= trace staining, grade 2= mild staining, grade 3= moderate staining, grade 4= severe staining. Data from different zones was combined and the total value was averaged.</description>
          <units>Scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.08" spread="0.895"/>
                    <measurement group_id="O2" value="2.08" spread="0.463"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Tear Meniscus Height</title>
        <description>Meniscus height measured in mm</description>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Parasol Group</title>
            <description>Randomized to receive Brand A punctal plugs
Parasol Punctal Occluder</description>
          </group>
          <group group_id="O2">
            <title>Superflex Group</title>
            <description>Randomized to receive Group B punctal plugs
Superflex Punctal Occluder</description>
          </group>
        </group_list>
        <measure>
          <title>Tear Meniscus Height</title>
          <description>Meniscus height measured in mm</description>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.472" spread="0.398"/>
                    <measurement group_id="O2" value="0.468" spread="0.217"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Parasol Group</title>
          <description>Randomized to receive Brand A punctal plugs
Parasol Punctal Occluder</description>
        </group>
        <group group_id="E2">
          <title>Superflex Group</title>
          <description>Randomized to receive Group B punctal plugs
Superflex Punctal Occluder</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Stephanie Baxter</name_or_title>
      <organization>Queen's University</organization>
      <phone>613 544 3310</phone>
      <email>baxters@baxtereyemd.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

